Obesity management presents a complex challenge for employers, who must balance population health goals with rising costs and uncertain outcomes. Employers should consider broad coverage approaches that include alternatives to GLP1 weight loss medications. Lower cost alternatives are available and have proven to be successful in supporting diverse patient needs.